Case Details

Decision Information

JAMP Pharma - CT-2024-006

Collection	Case Details
Date Filed	2024-07-26
File Number	CT-2024-006
Status	Ongoing
Type of Application	Abuse of Dominant Position Leave to Make Application under Sections 75, 76, 77 or 79
Section(s) of the Competition Act	s. 103.1; s. 79
Hearing Date	NA
Date Completed	NA

Decision Content

NOTE: Some of the documents on this web page have been provided by external sources and have been inserted, as received, in the language and format of record.
Questions or comments may be sent by e-mail to: tribunal@ct-tc.gc.ca

CT-2024-006 (JAMP Pharma)

JAMP Pharma Corporation v Janssen Inc.
Section(s):	s.103.1 - Leave to Make Application under Sections 75, 76, 77 or 79
Filed on:	2024-07-26
Status:	Ongoing

Applicant(s):	JAMP Pharma Corporation
Respondent(s):	Janssen Inc.

Hearing Date:	NA
Hearing Location:	NA
Panel Members:	Justice Andrew D. Little

Case Documents

Pleading(s)

Pleading(s)
#	Title	Date
1	Notice of Application pursuant to s. 103.1 of the Competition Act	2024-07-26
3	Proposed Notice of Application under s.79 of the Competition Act	2024-07-26
5	Affidavit of Amélie Faubert in support of s. 103.1 of the Competition Act	2024-07-26
8	Affidavit of Sukhad Juneja in support of s. 103.1 of the Competition Act	2024-07-26
9	Affidavit of Genia Radeva in support of s. 103.1 of the Competition Act	2024-07-26
10	Affidavit of Emily Seaby in support of s. 103.1 of the Competition Act	2024-07-26
13	Memorandum of Fact and Law	2024-07-26
14	Book of Authorities of the Applicant	2024-07-26
21	Affidavit of Sukhad Juneja in support of a Confidentiality Order	2024-08-12
45	Commissioner's written representation pursuant to subsection 103.1(6)	2024-09-09
49	Janssen's written representations pursuant to subsection 103.1(6)	2024-09-11
52	Affidavit of Andy Williams in support of Janssen's Response to the s. 103.1 Application	2024-09-11
55	JAMP's Book of Authorities in Reply	2024-09-13
58	JAMP's Reply Written Submissions	2024-09-13

Decision(s)

Decision(s)
#	Title	Date
18	Notice pursuant to subsection 103.1(5) of the Competition Act	2024-08-06
25	Confidentiality Order	2024-08-13
39	Direction re: time extension	2024-08-19
43	Reasons for Order and Order granting an application for leave to file affidavit evidence under Rule 119(3)	2024-08-26

Motions and Related Documents

Decision(s)
#	Title	Date
20	Informal Motion from JAMP Pharma re Confidentiality Order	2024-08-12
27	Informal motion from Janssen requesting leave to file responding affidavit evidence in an application for leave and time extension	2024-08-19
34	JAMP's response to Janssen's informal motion opposing Janssen's request for leave to file responding affidavit evidence and time extension	2024-08-19
38	Janssen's reply to its informal motion requesting leave to file responding affidavit evidence in an application for leave and time extension	2024-08-19

Other(s)

Decision(s)
#	Title	Date
17	Certification of the Commissioner pursuant to section 103.1	2024-07-31

You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.

Do not display this message anymore